IGCIGC Pharma, Inc.

NYSE igcpharma.com


$ 0.38 $ 0.01 (1.3 %)    

Thursday, 08-Aug-2024 11:12:02 EDT
QQQ $ 449.23 $ 13.30 (3.06 %)
DIA $ 395.05 $ 6.75 (1.74 %)
SPY $ 531.28 $ 11.99 (2.31 %)
TLT $ 95.30 $ -0.59 (-0.62 %)
GLD $ 224.00 $ 3.46 (1.57 %)
$ 0.391
-- x --
-- x --
-- - --
$ 0.25 - $ 0.91
331,377
na
29.57M
$ 1.60
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 06-24-2024 03-31-2024 10-K
3 02-14-2024 12-31-2023 10-Q
4 11-09-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 07-07-2023 03-31-2023 10-K
7 02-14-2023 12-31-2022 10-Q
8 11-01-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 06-22-2022 03-31-2022 10-K
11 02-10-2022 12-31-2021 10-Q
12 10-29-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
14 06-14-2021 03-31-2021 10-K
15 02-16-2021 12-31-2020 10-Q
16 11-20-2020 09-30-2020 10-Q
17 08-19-2020 06-30-2020 10-Q
18 07-13-2020 03-31-2020 10-K
19 02-10-2020 12-31-2019 10-Q
20 11-06-2019 09-30-2019 10-Q
21 08-09-2019 06-30-2019 10-Q
22 06-14-2019 03-31-2019 10-K
23 02-12-2019 12-31-2018 10-Q
24 10-16-2018 09-30-2018 10-Q
25 08-03-2018 06-30-2018 10-Q
26 06-21-2018 03-31-2018 10-K
27 02-20-2018 12-31-2017 10-Q
28 11-17-2017 09-30-2017 10-Q
29 08-18-2017 06-30-2017 10-Q
30 07-14-2017 03-31-2017 10-K
31 02-21-2017 12-31-2016 10-Q
32 11-21-2016 09-30-2016 10-Q
33 08-16-2016 06-30-2016 10-Q
34 07-14-2016 03-31-2016 10-K
35 02-16-2016 12-31-2015 10-Q
36 11-13-2015 09-30-2015 10-Q
37 08-14-2015 06-30-2015 10-Q
38 07-14-2015 03-31-2015 10-K
39 02-12-2015 12-31-2014 10-Q
40 11-13-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 igc-pharma-q1-2025-gaap-eps-003-inline-sales-272000k-miss-310000k-estimate

IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 25 per...

 ascendiant-capital-maintains-buy-on-igc-pharma-raises-price-target-to-35

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $3.25 to $...

Core News & Articles

https://x.com/POTUS/status/1813565568454127970

 alliance-global-partners-initiates-coverage-on-igc-pharma-with-buy-rating-announces-price-target-of-35

Alliance Global Partners analyst James Molloy initiates coverage on IGC Pharma (AMEX:IGC) with a Buy rating and announces Pr...

Core News & Articles

https://www.marijuanamoment.net/gop-congressional-committee-approves-bill-to-block-marijuana-rescheduling-while-rejecting-state...

 igc-pharma-preliminary-preclinical-analyses-of-tgr-63-demonstrate-blood-brain-barrier-permeability-and-safety-profile-and-shows-no-adverse-effects

- Preliminary Analysis confirms the presence of TGR-63 in brain tissue and shows no adverse effects. -IGC Pharma, Inc. (NYSE:IG...

Core News & Articles

https://www.marijuanamoment.net/california-legislature-approves-bill-to-break-psychedelics-research-logjam-sending-it-to-governor/

 igc-pharma-q4-2024-gaap-eps-004-sales-295000k-beat-193000k-estimate

IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.04) per share. The company reported quarterly sales of $295.000 thousan...

 ascendiant-capital-reiterates-buy-on-igc-pharma-maintains-325-price-target

Ascendiant Capital analyst Edward Woo reiterates IGC Pharma (AMEX:IGC) with a Buy and maintains $3.25 price target.

 igc-pharma-publishes-study-in-european-society-of-medicine-for-impact-of-cyp2c9-genetic-polymorphism-on-pharmacokinetics-of-delta-9-tetrahydrocannabinol

-- Study Deepens Understanding of Treatments for Alzheimer's Patients, Enabling More Effective Treatments --

Core News & Articles

https://subscriber.politicopro.com/article/2024/05/justice-department-poised-to-post-plans-for-marijuana-reclassification-00158...

Core News & Articles

https://www.marijuanamoment.net/dea-appears-to-question-marijuanas-medical-value-despite-rescheduling-recommendation/ 

Core News & Articles

https://twitter.com/KevinSabet/status/1787569052782846142 

Core News & Articles

https://www.marijuanamoment.net/florida-gop-formally-opposes-marijuana-legalization-ballot-initiative-clearing-path-for-desanti...

Core News & Articles

https://www.wsj.com/finance/regulation/declassifying-cannabis-still-leaves-pot-stocks-in-limbo-26d417ec

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION